
Alintosch Pharmaceuticals Private Limited
About Alintosch Pharmaceuticals Private Limited
Data last updated:
Alintosch Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 September 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PTC040884. Its GSTIN is 27AAACA4487A3ZX (Maharashtra). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹45 Lakh. It was formerly known as Alintosch Pharmaceuticals Ltd. It is led by directors including Bharatbhushan Krishnakant Shrikhande and Siddhesh Suresh Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/704 Pramukh Plaza Cardinal Gracious Road Chakala Andheri East, Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2024, the company reported a revenue of ₹32.01 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net loss of ₹50.66 Lakh (net margin -158.3%) and EBITDA of ₹18.15 Lakh (EBITDA margin 56.7%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Alintosch Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH1986PLC040884. The current CIN is U24230MH1986PTC040884, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1986PTC040884 | Current |
| U24230MH1986PLC040884 | Previous |
Contact details
Alintosch Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/704 Pramukh Plaza Cardinal Gracious Road Chakala Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alintosch Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Alintosch Pharmaceuticals Private Limited
FY 2025 filings availableAlintosch Pharmaceuticals Private Limited reported revenue of ₹32.01 Lakh (up 36% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 36% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹50.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 56.7% | ||||
| Net Profit Margin | -158.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alintosch Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alintosch Pharmaceuticals Private Limited
Alintosch Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bharatbhushan Krishnakant Shrikhande Also directs: Siddhayu Life Sciences Private Limited, Siddhayu Healthcare Private Limited, Dev-Dwarka Windproject Limited and 5 more | Director | 14 Sep 1991 | 35 Years 2 Months | Current |
| Siddhesh Suresh Sharma | Director | 15 Sep 2003 | 23 Years 2 Months | Current |
| Pranavkumar Sureshkumar Sharma | Director | 15 Sep 2003 | 23 Years 2 Months | Current |
Peer comparison
Alintosch Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mebo Pharmaceutical (India) Private Limited | ₹32.07 Lakh (FY 2025) | -9.0% | New Delhi, Delhi, India | |||
| Moonlight Pharmaceuticals Private Limited | ₹32.07 Lakh (FY 2017) | 16.0% | Sri Ganganagar, Rajasthan, India | |||
| Answer Pharmaceuticals Private Limited | ₹32.05 Lakh (FY 2024) | 28.0% | Patna, Bihar, India | |||
| Alintosch Pharmaceuticals Private Limitedthis company | ₹32.01 Lakh (FY 2024) | -₹50.66 Lakh | -158.3% | 36.0% | Mumbai, Maharashtra, India | |
| Alyssum Pharma Private Limited | ₹31.99 Lakh (FY 2024) | -1.0% | Bhopal, Madhya Pradesh, India | |||
| Mega Biosciences Private Limited | ₹31.95 Lakh (FY 2024) | -24.0% | New Delhi, Delhi, India | |||
| Taparia Tex Fab Private Limited | ₹31.94 Lakh (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| G 7 Biopharmaceutical Private Limited | ₹31.94 Lakh (FY 2025) | 41.0% | Wadi, Maharashtra, India |
To see the full peer comparison of Alintosch Pharmaceuticals Private Limited, buy the company report.
Auditor
Alintosch Pharmaceuticals Private Limited is audited by J & K AGARWAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J & K AGARWAL & CO. | FY 2023 | 100071W |
Shareholding
The shareholding of Alintosch Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alintosch Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Sep 2022 | 100642740 | Others | ₹5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Alintosch Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alintosch Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alintosch Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA4487A3ZX | Maharashtra | Active | 25 Oct 2023 |
To see the full GST registrations and return filing status of Alintosch Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alintosch Pharmaceuticals Private Limited has 7 board changes on record since 1991: 3 appointments and 4 cessations. The latest: Kalpana Suresh Sharma ceased to be Director on 31 Jan 2022.
Frequently asked questions
Alintosch Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 September 1986 (40+ years old) and is registered under CIN U24230MH1986PTC040884.
Alintosch Pharmaceuticals has 3 current directors:
- Bharatbhushan Krishnakant Shrikhande - Director
- Siddhesh Suresh Sharma - Director
- Pranavkumar Sureshkumar Sharma - Director
The latest financial statements of Alintosch Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alintosch Pharmaceuticals is 27AAACA4487A3ZX, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Alintosch Pharmaceuticals is U24230MH1986PTC040884. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alintosch Pharmaceuticals was incorporated on 11 September 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Alintosch Pharmaceuticals by revenue are Mebo Pharmaceutical (India) Private Limited, Moonlight Pharmaceuticals Private Limited, Answer Pharmaceuticals Private Limited, Alyssum Pharma Private Limited, Mega Biosciences Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Kalpana Suresh Sharma ceased to be Director on 31 Jan 2022. Sureshkumar Ramnarayan Sharma ceased to be Additional Director on 09 Sep 2016. Chandrashekhar Pashupatinath Karundia ceased to be Director on 28 May 2014. Alintosch Pharmaceuticals has 7 board changes on record in total.
The registered office of Alintosch Pharmaceuticals is at C704 Pramukh Plaza Cardinal Gracious Road Chakala Andheri East, Mumbai, Maharashtra, India – 400069.
Alintosch Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Alintosch Pharmaceuticals has open charges of ₹5 Cr and no satisfied charges on record as per latest MCA filings.

